CIR
ANIK icon

Clear Investment Research’s Anika Therapeutics ANIK Stock Holding History

Clear Investment Research’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4
Closed – – 126
2019
Q3 		$0 Hold
4
– – ﹤0.01% 236
2019
Q2 		$0 Hold
4
– – ﹤0.01% 236
2019
Q1 		$0 Hold
4
– – ﹤0.01% 227
2018
Q4 		$0 Hold
4
– – ﹤0.01% 218
2018
Q3 		$0 Buy
+4
New +$158 ﹤0.01% 232

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Clear Investment Research's ANIK Position: Q4 2019 in Review

Clear Investment Research sold out of Anika Therapeutics (ANIK) in Q4 2019, closing a stake of 4 shares.

Clear Investment Research first reported a position in ANIK in Q3 2018 and held it in 5 quarters. The position peaked at $0 in Q3 2019. 191 funds tracked by Wall St. Rank hold ANIK as of Q4 2019.

  • Clear Investment Research reported no remaining Anika Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Clear Investment Research sold 4 Anika Therapeutics shares in Q4 2019.
  • Clear Investment Research first reported a position in Anika Therapeutics in Q3 2018 and held it in 5 quarters.
  • Clear Investment Research's Anika Therapeutics position peaked at $0 in Q3 2019.
  • 191 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2019.

Based on Clear Investment Research's 13F filing for Q4 2019, filed 4 Feb 2020.